Linda Mutter

4.6k total citations
8 papers, 383 citations indexed

About

Linda Mutter is a scholar working on Clinical Biochemistry, Molecular Biology and Epidemiology. According to data from OpenAlex, Linda Mutter has authored 8 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Clinical Biochemistry, 2 papers in Molecular Biology and 2 papers in Epidemiology. Recurrent topics in Linda Mutter's work include Metabolism and Genetic Disorders (3 papers), Nail Diseases and Treatments (2 papers) and Amino Acid Enzymes and Metabolism (1 paper). Linda Mutter is often cited by papers focused on Metabolism and Genetic Disorders (3 papers), Nail Diseases and Treatments (2 papers) and Amino Acid Enzymes and Metabolism (1 paper). Linda Mutter collaborates with scholars based in United States, United Kingdom and Japan. Linda Mutter's co-authors include Martin K. Ellis, W. McLean Provan, Michael P. Prisbylla, Thomas H. Cromartie, David L. Lee, Torquil Fraser, Mervyn Robinson, Lewis L. Smith, Edward A. Lock and T.R. Auton and has published in prestigious journals such as Journal of the American Chemical Society, The Journal of Organic Chemistry and Toxicology and Applied Pharmacology.

In The Last Decade

Linda Mutter

8 papers receiving 358 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Linda Mutter United States	7	123	120	101	83	81	8	383
Michael P. Prisbylla United Kingdom	8	148 1.2×	121 1.0×	102 1.0×	183 2.2×	81 1.0×	8	489
Tsutomu Nakatsugawa United States	14	118 1.0×	239 2.0×	20 0.2×	66 0.8×	125 1.5×	31	537
Luana E. Staiger United States	11	97 0.8×	62 0.5×	32 0.3×	18 0.2×	29 0.4×	26	319
Nobuo Miki Japan	10	178 1.4×	127 1.1×	13 0.1×	31 0.4×	14 0.2×	25	412
J. Jayaraman India	13	494 4.0×	40 0.3×	35 0.3×	37 0.4×	11 0.1×	49	652
M. W. KERR United Kingdom	12	197 1.6×	221 1.8×	13 0.1×	28 0.3×	37 0.5×	19	390
Renata Finollo Italy	11	162 1.3×	60 0.5×	36 0.4×	24 0.3×	8 0.1×	24	350
P. Mende Germany	10	217 1.8×	49 0.4×	59 0.6×	24 0.3×	3 0.0×	19	356
Erik C. Ralph United States	10	227 1.8×	149 1.2×	13 0.1×	56 0.7×	38 0.5×	16	459
Małgorzata Juszczak Poland	11	177 1.4×	60 0.5×	10 0.1×	126 1.5×	16 0.2×	20	374

Countries citing papers authored by Linda Mutter

Since Specialization

Citations

This map shows the geographic impact of Linda Mutter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linda Mutter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linda Mutter more than expected).

Fields of papers citing papers by Linda Mutter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linda Mutter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linda Mutter. The network helps show where Linda Mutter may publish in the future.

Co-authorship network of co-authors of Linda Mutter

This figure shows the co-authorship network connecting the top 25 collaborators of Linda Mutter. A scholar is included among the top collaborators of Linda Mutter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linda Mutter. Linda Mutter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Sanada, Hisakazu, et al.. (2014). Nonclinical safety assessment of Efinaconazole Solution (10%) for onychomycosis treatment. Regulatory Toxicology and Pharmacology. 70(1). 242–253. 8 indexed citations

Sanada, Hisakazu, et al.. (2014). Efinaconazole: Developmental and reproductive toxicity potential of a novel antifungal azole. Reproductive Toxicology. 52. 18–25. 17 indexed citations

Chen, Linda, Mark Dreyer, Stephen B. Freedman, et al.. (2011). Discovery of a potent, orally bioavailable pyrimidine VLA-4 antagonist effective in a sheep asthma model. Bioorganic & Medicinal Chemistry Letters. 21(6). 1741–1743. 4 indexed citations

Lock, Edward A., Martin K. Ellis, Mervyn Robinson, et al.. (1998). From toxicological problem to therapeutic use: The discovery of the mode of action of 2‐(2‐nitro‐4‐trifluoromethylbenzoyl)‐1,3‐cyclohexanedione (NTBC), its toxicology and development as a drug. Journal of Inherited Metabolic Disease. 21(5). 498–506. 89 indexed citations

Lee, David L., Michael P. Prisbylla, Thomas H. Cromartie, et al.. (1997). The discovery and structural requirements of inhibitors of p-hydroxyphenylpyruvate dioxygenase. Weed Science. 45(5). 601–609. 168 indexed citations

Lock, Edward A., Martin K. Ellis, W. McLean Provan, et al.. (1996). Tissue Distribution of 2-(2-Nitro-4-trifluoromethylbenzoyl)cyclohexane-1,3-dione (NTBC): Effect on Enzymes Involved in Tyrosine Catabolism and Relevance to Ocular Toxicity in the Rat. Toxicology and Applied Pharmacology. 141(2). 439–447. 41 indexed citations

Kanne, David B., et al.. (1986). Synthesis of the first highly potent bridged nicotinoid 9-Azabicyclo[4.2.1]nona[2,3-c]pyridine (pyrido[3,4-b]homotropane). Journal of the American Chemical Society. 108(24). 7864–7865. 42 indexed citations

Smith, Grant Gill, et al.. (1977). Steric effects in homogeneous gas-phase reactions. Pyrolysis of isopropyl esters. The Journal of Organic Chemistry. 42(1). 44–47. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact